Blencowe Resources: Aspiring to become one of the largest graphite producers in the world. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlanbia Regulatory News (GLB)

Share Price Information for Glanbia (GLB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 16.86
Bid: 16.86
Ask: 18.44
Change: -1.58 (-8.57%)
Spread: 1.58 (9.371%)
Open: 16.86
High: 16.86
Low: 16.86
Prev. Close: 18.44
GLB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Directorate Change

4 May 2023 07:05

RNS Number : 3454Y
Glanbia PLC
04 May 2023
 

Board Director appointment

 

4 May 2023, Glanbia plc, the better nutrition company, is announcing the appointment of Ms Gabriella Parisse to its Board as an Independent Non-Executive Director effective 1 June 2023. On appointment Gabriella will also join the Board Development Committee.

 

Gabriella brings to the Glanbia Board significant experience in consumer brand development, the food ingredients industry, innovation and strategic leadership of multinational businesses.

 

Gabriella is an Italian citizen and currently resides in the USA where she is President and CEO of Velcro Companies, a global manufacturer of innovative fastening solutions for a broad range of end markets. She has more than 35 years of international experience in consumer goods and business to business industries with a track-record in accelerating growth, brand building and innovation. For a significant proportion of her career she has been performing senior roles based in North America. Gabriella joined Velcro Companies in October 2018 as Chief Marketing Officer & President of the Consumer division, and prior to her appointment as CEO in 2021 served as Chief Growth Officer.

 

Since 2022, Gabriella also serves as a member of the New England Advisory Council of the Federal Reserve Bank of Boston.

 

Prior to Velcro Companies, Gabriella served on the Executive Committee of Tate & Lyle plc a global food ingredients business, as President, Innovation and Commercial Development, reporting to the CEO. Previously, Gabriella spent 26 years with Johnson & Johnson. She served in a variety of global senior leadership roles with increasing responsibility in marketing, innovation and business development, including President of Johnson & Johnson Consumer Italy and Vice President, Skincare for Europe, Africa and Middle East.

 

Gabriella holds a master's degree in Statistic & Demographic Sciences from La Sapienza University in Rome. In 2009, she was awarded the Order of Merit for Labor title ("Cavaliere del Lavoro") by the President of the Italian Republic.

 

Compliance with Listing Rules

Gabriella has notified Glanbia plc that, save as disclosed herein, she does not have any details to be disclosed as required under Paragraph 6.1.66, Chapter 6 of the Euronext Dublin Listing Rules and Paragraph 9.6.13, Chapter 9 of the UK Listing Rules.

 

Board structure

Following Gabriella's appointment, the Board will comprise of 13 members including, the Chairman, two Executive Directors, three representatives from Tirlán Co-operative Society Limited and seven Independent Non-Executive Directors. Female representation on the Board will increase to 46% including five of the seven Independent Non-Executive Directors.

 

ENDS

For further information contact

Glanbia plc +353 56 777 2200

Liam Hennigan, Group Secretary & Head of Investor Relations: +353 86 046 8375

Martha Kavanagh, Head of Corporate Communications: +353 87 646 200

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEAESDEEPDEAA
Date   Source Headline
10th May 20243:00 pmRNSDirectorate Change
10th May 20247:00 amRNSTransaction in Own Shares
9th May 20247:00 amRNSTransaction in Own Shares
8th May 202412:24 pmRNSDirector/PDMR Shareholding
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
2nd May 202410:16 amRNSDirectorate Change
1st May 20244:35 pmRNSResult of AGM
1st May 20247:00 amRNSFirst Quarter 2024 IMS
1st May 20247:00 amRNSTransaction in Own Shares
30th Apr 20243:32 pmRNSTotal Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20247:00 amRNSTransaction in Own Shares
26th Apr 20243:49 pmRNSCompletion of acquisition of Flavor Producers
26th Apr 20247:00 amRNSTransaction in Own Shares
25th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
23rd Apr 20247:00 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
18th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSGlanbia agrees to acquire Flavor Producers
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSTransaction in Own Shares
8th Apr 20247:00 amRNSTransaction in Own Shares
5th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 202410:17 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 202411:58 amRNSDirector/PDMR Shareholding
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSTransaction in Own Shares
19th Mar 20242:14 pmRNSNotice of AGM
19th Mar 20247:00 amRNSTransaction in Own Shares
18th Mar 20247:00 amRNSTransaction in Own Shares
15th Mar 20247:00 amRNSTransaction in Own Shares
14th Mar 20247:00 amRNSTransaction in Own Shares
13th Mar 20247:00 amRNSTransaction in Own Shares
12th Mar 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.